- Home
- NRT vs DXR Comparison
NRT vs DXR Comparison
Compare NRT & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRT
- DXR
- Stock Information
- Founded
- NRT 1975
- DXR 1970
- Country
- NRT United States
- DXR United States
- Employees
- NRT N/A
- DXR N/A
- Industry
- NRT Oil & Gas Production
- DXR Medical/Dental Instruments
- Sector
- NRT Energy
- DXR Health Care
- Exchange
- NRT Nasdaq
- DXR Nasdaq
- Market Cap
- NRT 43.1M
- DXR 36.4M
- IPO Year
- NRT N/A
- DXR N/A
- Fundamental
- Price
- NRT $5.08
- DXR $8.10
- Analyst Decision
- NRT
- DXR Strong Buy
- Analyst Count
- NRT 0
- DXR 1
- Target Price
- NRT N/A
- DXR $25.00
- AVG Volume (30 Days)
- NRT 42.3K
- DXR 3.8K
- Earning Date
- NRT 05-30-2025
- DXR 01-01-0001
- Dividend Yield
- NRT 9.25%
- DXR N/A
- EPS Growth
- NRT N/A
- DXR 86.16
- EPS
- NRT 0.56
- DXR 0.11
- Revenue
- NRT $5,942,748.00
- DXR $119,714.00
- Revenue This Year
- NRT N/A
- DXR N/A
- Revenue Next Year
- NRT N/A
- DXR N/A
- P/E Ratio
- NRT $9.04
- DXR $74.49
- Revenue Growth
- NRT N/A
- DXR N/A
- 52 Week Low
- NRT $3.88
- DXR $6.55
- 52 Week High
- NRT $7.19
- DXR $10.00
- Technical
- Relative Strength Index (RSI)
- NRT 62.64
- DXR 57.71
- Support Level
- NRT $4.36
- DXR $7.57
- Resistance Level
- NRT $5.19
- DXR $8.13
- Average True Range (ATR)
- NRT 0.23
- DXR 0.28
- MACD
- NRT 0.03
- DXR 0.07
- Stochastic Oscillator
- NRT 86.75
- DXR 85.52
About NRT North European Oil Royality Trust
North European Oil Royalty Trust holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The properties of the trust are overriding royalty rights on sales of gas, sulfur, and oil under certain concessions or leases in the Federal Republic of Germany. The trust also holds other royalty rights, which are based on leases. It receives various percentages of royalties on the proceeds of the sales of certain products from the areas involved.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.